Peer-reviewed veterinary case report
Managing type 2 diabetes and infectious peritonitis in a Persian
By Nashrullah, Fathul Barry Akbar et al.·Published in ARSHI Veterinary Letters·2025·View original on Crossref →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Management of type 2 diabetes mellitus and feline infectious peritonitis in a Persian Peaknose cat
- Species:
- cat
Plain-English summary
A 7-year-old male Persian Peaknose cat was brought in for severe weight loss, increased thirst, and frequent urination. He was diagnosed with type 2 diabetes and a serious infection called feline infectious peritonitis (FIP). The vet treated him with a combination of medications, including Glimepiride to help manage his blood sugar, along with supportive treatments and a special low-sugar diet. Over the course of a week, his blood glucose levels improved, although they remained higher than normal. This case shows the importance of a comprehensive treatment plan for cats with multiple health issues.
People also search for: cat diabetes treatment · Persian cat weight loss · feline infectious peritonitis management · high blood sugar in cats · low sugar diet for cats
Abstract
Feline diabetes mellitus (DM) and infectious peritonitis (FIP) are challenging metabolic and infectious diseases in cats that require long-term management and therapeutic strategies. This case report describes the clinical management of a 7-year-old male Persian peaknose cat diagnosed with type 2 DM and non-effusive FIP at the West Java Animal Hospital. The cat presented with polyuria, polydipsia, and severe weight loss over seven days. Hematological findings showed hyperchromic microcytic anemia and elevated MID%, while biochemical analysis indicated hyperglycemia (524 mg/dL), increased ALT, and a low albumin-to-globulin (A/G) ratio (0.6), consistent with type 2 DM and FIP. Treatment included Molnupiravir, Glimepiride as an antihyperglycemic agent; Ornipural for hepatodigestive support; vitamin supplementation (B complex, A, D, and E); and a low-sugar diet. Blood glucose levels monitored daily for seven days showed a progressive decrease but remained above the normal threshold. This case demonstrates the importance of comprehensive management combining causative, symptomatic, and supportive therapies in feline patients with concurrent disorders. This highlights the need for glucose monitoring, nutritional adjustment, and client education regarding insulin therapy to achieve glycemic control in complex feline comorbidities.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on Crossref: https://doi.org/10.29244/avl.9.3.65-66